Tag Archives: Testing

Lyric (Formerly ClaimsXten Portfolio) To Add Genetic Testing Edit Module To Its Market-Leading Payment Accuracy Solutions

At the end of April, ClaimsXten Portfolio, the market leader in claims modification solutions, became Lyric, with the aim of simplifying the assistance business. Strategic partnership announced today combines Lyric’s market-leading statement editing solution with Concert Genetics machine learning models and proprietary genetic testing market data and will help address pain points for health plans… Read More »

Huge underuse of germline testing for cancer patients

CHICAGO Fewer than 7 percent of newly diagnosed cancer patients are tested for germline gene mutations, and the percentage tested was even lower among racial and ethnic minorities, a huge study has found. Information from germline genetic testing could affect a patient’s cancer care. For example, such tests could indicate that targeted therapies would be… Read More »

Potentially life-saving genetic testing after cancer diagnosis underused

06 June Potentially life-saving genetic testing after cancer diagnosis underused MedicalResearch.com Interview with: Doctor Kurian Allison W. Kurian, MD, M.Sc.Professor of Medicine and of Epidemiology and Population HealthAssociate Chief, Division of OncologyCo-director, Population Sciences Program, Stanford Cancer InstituteDirector, Female Clinical Cancer Genetics ProgramStanford University School of MedicineStanford, Calif. 94305-5405 MedicalResearch.com: What is the background of… Read More »

Few patients receive recommended genetic testing after a cancer diagnosis

These are not controversial, he said. These are not situations where some people think these patients should be tested and some people think they shouldn’t. Of course they should be. While this study didn’t look at the reasons behind the low testing rates, previous studies suggest that some cancer patients don’t get information about genetic… Read More »